MALIGNANT ANORECTAL NEOPLASM

This adverse event was reported 75 times

These drugs are most commonly taken by patients reporting MALIGNANT ANORECTAL NEOPLASM:

# Drug Count
0 INFLIXIMAB 11
1 ADALIMUMAB 8
2 PREDNISONE 7
3 RITONAVIR 6
4 RITONAVIR 100 MG 6
5 EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 5
6 ENTECAVIR 5
7 ENTECAVIR ANHYDROUS 5
8 MESALAMINE 5
9 OXALIPLATIN 5
See all common drugs associated with MALIGNANT ANORECTAL NEOPLASM

MALIGNANT ANORECTAL NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SECNIDAZOLE 1 0.0035
1 EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 5 0.0004
2 ENTECAVIR 5 0.0004
3 RITONAVIR 100 MG 6 0.0004
4 EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE 1 0.0003
5 ACARBOSE 1 0.0003
6 FRUQUINTINIB 1 0.0003
7 VONOPRAZAN FUMARATE 2 0.0002
8 CALCIUM FOLINATE 1 0.0002
9 CAPTOPRIL 2 0.0002
See all drugs enriched for association with MALIGNANT ANORECTAL NEOPLASM